Atherectomy Devices Market is valued at USD 1.45 Billion in 2021 and expected to reach USD 2.29 Billion by 2028 with the CAGR of 6.75% over the forecast period.
Rising prevalence of coronary & peripheral artery diseases and growing healthcare expenditure are key factors driving the growth of Global Atherectomy Devices Market.
Atherectomy can be defined as a minimally invasive endovascular surgery technique for removing atherosclerosis from blood vessels within the body. It is used as an alternative to angioplasty for the treatment of peripheral artery disease, but the studies that exist are not adequate to determine if it is superior to angioplasty. It has also been used to treat coronary artery disease, albeit without evidence of superiority to angioplasty. The use of atherectomy instead of or in addition to angioplasty remains an area of controversy, as atherectomy naturally includes the use of more costly disposable devices, and clear indication to justify its use is lacking. It is a technique applied to eliminate atherosclerotic plaque from affected arteries. It is used widely in cure of both peripheral and coronary arterial ailments.
Global Atherectomy Devices market report is segmented on the basis of indication, end-user, type and region & country level. Based upon indication, atherectomy devices market is classified into coronary artery diseases and peripheral artery diseases. Based upon end-user, the market is classified into hospitals, ambulatory surgical centers and office-based lab. Based upon type, atherectomy devices market is classified into directional atherectomy, rotational atherectomy, orbital atherectomy and laser atherectomy.
The regions covered in this Atherectomy Devices market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Atherectomy Devices is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Atherectomy Devices market report covers prominent players are Medtronic Plc., Boston Scientific Corp., Avinger Inc., Koninklijke Philips N.V, Abbott Laboratories, Braun Melsungen Ag Cardinal Health, Terumo Corporation, C. R. Bard, Inc., Straub Medical AG., Abbott Laboratories, Minnetronix, Inc. , Biomerics and others.
|2018 - 2021
|2021 - 2028
|Market Size in 2021:
|USD 1.45 Billion
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2028:
|USD 2.29 Billion
|Tables, Charts & Figures:
|Atherectomy Devices Key Players
|Medtronic Plc., Boston Scientific Corp., Avinger Inc., Koninklijke Philips N.V, Abbott Laboratories, Braun Melsungen Ag Cardinal Health, Terumo Corporation, C. R. Bard, Inc., Straub Medical AG., Abbott Laboratories, Minnetronix, Inc. , Biomerics and others.
|By Indication, By Type, By End-User
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
AngioDynamics Announced Commercial Launch of Auryon Atherectomy System in United States
September 21st, 2020; AngioDynamics, Inc. announced the launch of the Auryon Atherectomy System, a newly-developed innovative technology for the treatment of Peripheral Artery Disease (PAD),including Critical Limb Ischemia (CLI) and In-Stent Restenosis (ISR). The Auryon Atherectomy System uses revolutionary technology to deliver powerful treatment of PAD lesions and occlusions. The Auryon Atherectomy System is the first laser atherectomy system to efficiently treat lesions of any type, length, or location (above and below the knee), with minimal impact on vessel walls1. The Auryon Atherectomy System uses solid-state laser technology for the treatment of PAD and is FDA cleared with an indication for treatment of infrainguinal stenoses and occlusions, including ISR.
Global Atherectomy Devices Market Dynamics–
The global Atherectomy Devices market is witnessing substantial growth due to rising prevalence of coronary & peripheral artery diseases and growing healthcare expenditure. According to the global PAD study, PAD, as measured by the abnormal ankle-brachial index (ABI, the ratio of the systolic blood pressure at the ankle to the systolic blood pressure in the arm) seems to affect roughly 202 million people in the world, more than two thirds of whom residing in low- and middle-income countries (LMIC). Between 2000 and 2020, the total number of Chinese people with PAD is expected to increase by 40%: from 29.44 million (95% CI = 22.51-38.62) in 2000 to 41.13 million (95% CI = 32.00-52.95) in 2020. And between 2000 and 2010, the number of affected people worldwide were increased by 23.51%, where the increasing rate in LMIC was twice higher than that in high-income countries (HIC) (28.67% vs 13.08%). However, high соѕt of rеѕеаrсh and dеvеlорmеnt and ѕресіаltу еquірmеnt for lаѕеr рrосеdurеѕ and ѕtrіngеnt gоvеrnmеnt rеgulаtіоnѕ are expected to hamper the market growth. In spite of that, increasing technological advancements in this field can create great opportunities for further growth of the global atherectomy devices market.
Global Atherectomy Devices Market Regional Analysis–
North America is expected to dominate the global atherectomy devices market with the potential rate due to extensive investment in research & development in this region. The Asia pacific is expected to emerge as the fastest-growing regional market over the forecast period due to the increasing patient awareness regarding the diagnosis of peripheral coronary diseases and benefits of atherectomy. In addition, increasing geriatric population and increasing prevalence of heart diseases are also supplementing the market growth in this region. For example; According to the Indian Heart Association; 50% of all heart attacks in Indians occur under 50 years of age and 25% of all heart attacks in Indians occur under 40 years of age. In India, more than 17 Lakh people die every year due to heart diseases and by 2030, the figure is expected to increase with 2.3 crore deaths. Around 26 percent of total deaths in India occur due to non-communicable diseases (NCD), largely referred to the heart diseases and diabetes.
Regional & Country Analysis
Middle East and Africa
Key Benefits of Global Atherectomy Devices Market Report–
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®